Share on StockTwits

Shares of Cardinal Health (NYSE:CAH) have received a consensus recommendation of “Buy” from the nineteen ratings firms that are covering the company, AR Network reports. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $76.53.

Several analysts have recently commented on the stock. Analysts at Robert W. Baird raised their price target on shares of Cardinal Health from $80.00 to $82.00 in a research note on Wednesday, July 9th. Separately, analysts at Zacks downgraded shares of Cardinal Health from an “outperform” rating to a “neutral” rating in a research note on Wednesday, June 11th. They now have a $74.00 price target on the stock. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a research note on Monday, June 2nd. They now have a $76.00 price target on the stock.

Cardinal Health (NYSE:CAH) opened at 71.06 on Tuesday. Cardinal Health has a 52 week low of $49.33 and a 52 week high of $74.40. The stock’s 50-day moving average is $69.7 and its 200-day moving average is $68.93. The company has a market cap of $24.175 billion and a P/E ratio of 70.58.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, May 1st. The company reported $1.01 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.01. The company had revenue of $21.40 million for the quarter, compared to the consensus estimate of $21.72 million. During the same quarter in the previous year, the company posted $1.02 earnings per share. The company’s revenue for the quarter was down 12.7% on a year-over-year basis. On average, analysts predict that Cardinal Health will post $3.82 earnings per share for the current fiscal year.

In other Cardinal Health news, CFO Jeffrey William Henderson sold 23,632 shares of the stock on the open market in a transaction dated Monday, July 14th. The shares were sold at an average price of $70.65, for a total value of $1,669,600.80. The transaction was disclosed in a filing with the SEC, which is available at this link.

Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.